CUE / Cue Biopharma, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Cue Biopharma, Inc.

Deler fremragende 3,255,359 shares
Insideraktier473.603 shares
Insider ejerskab14,55 %
Total Insiders25
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
1096 out of 10951

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
970 out of 10791

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Cue Biopharma, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Rodolfo Chaparro EVP, Head of Immunology - [O] 890.000 29.667
Anthony Digiandomenico Director - [D] 30.000 1.000
Frederick W Driscoll Director - [D] 0 0
Fletcher Aaron G.L. Director - [D] 940.000 31.333
Michael J Fox Director - [D] 100.000 3.333
Cameron Gray Director - [D] 687.049 22.902
Tamar D Howson 10.000
Peter A Kiener Director - [D] 357 12
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Matteo Levisetti Chief Medical Officer - [O] 9.230 308
Shao-Lee Lin CHIEF EXECUTIVE OFFICER, Director - [D] [O] 327.537 327.537
Christopher A Marlett Director - [D] 0 0
Steven L Mcknight 8.000
Bethany Mancilla SVP and Chief Business Officer - [O] 0 0
Kerri-Ann Millar CHIEF FINANCIAL OFFICER - [O] 14.311 477
Frank Morich Director - [D] 28.000 933
Patricia Nasshorn 10.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Daniel R Passeri CHIEF EXECUTIVE OFFICER, Director - [D] [O] 164.578 5.486
Kenneth Pienta Chief Medical Officer - [O] 2.000 67
Gary Alan Schuman Interim CFO - [O] 133.500 4.450
Colin Sandercock SVP, General Counsel and Sec - [O] 17.125 571
Pasha Sarraf Director - [D] 323.857 10.795
Seidel Ronald D. III EVP, Head of R&D - [O] 890.000 29.667
Simon Barry J. 10.000
Anish Suri PRESIDENT AND CSO - [O] 135.638 4.521
Patrick Verheyen Director - [D] 16.348 545

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CUE / Cue Biopharma, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-12-30 Sarraf Pasha 77.417 0,3016 2.581 9,0480 23.349 128 35.7300 68.835 294,82
2025-12-30 Sarraf Pasha 78.116 0,3114 2.604 9,3420 24.325
2025-12-30 Sarraf Pasha 86.947 0,3174 2.898 9,5220 27.597
2025-12-30 Sarraf Pasha 77.148 0,3003 2.572 9,0090 23.168
2025-12-30 Sarraf Pasha 4.229 0,3094 141 9,2820 1.308
2024-12-16 PASSERI DANIEL R 30.000 1,0300 1.000 30,9000 30.900
2023-08-25 Suri Anish 4.000 2,7600 133 82,8000 11.040
2023-08-14 PASSERI DANIEL R 3.000 2,8600 100 85,8000 8.580
2022-05-27 Morich Frank 28.000 3,7500 933 112,5000 105.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CUE / Cue Biopharma, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CUE / Cue Biopharma, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-03-23 Kiener Peter A 9.325 3,2800 311 98,4000 30.586 214 1.7200 -30.053 -98,26
2019-12-31 MARLETT CHRISTOPHER A 9.000 15,7100 300 471,3000 141.390
2019-12-31 MARLETT CHRISTOPHER A 6.700 15,7700 223 473,1000 105.659
2019-12-27 MARLETT CHRISTOPHER A 9.000 17,2400 300 517,2000 155.160
2019-12-26 MARLETT CHRISTOPHER A 19.647 17,5300 655 525,9000 344.412
2019-12-23 MARLETT CHRISTOPHER A 17.000 16,8200 567 504,6000 285.940
2019-12-19 MARLETT CHRISTOPHER A 4.000 17,0000 133 510,0000 68.000
2019-12-17 MARLETT CHRISTOPHER A 20.732 15,7300 691 471,9000 326.114

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CUE / Cue Biopharma, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-05-07 2026-05-03 4 Lin Shao-Lee CUE Common Stock A - Award D 327.537 327.537
2026-01-02 2025-12-30 4 Sarraf Pasha CUE Common Stock P - Purchase D 0,3016 77.417 23 323.857
2026-01-02 2025-12-30 4 Sarraf Pasha CUE Common Stock P - Purchase D 0,3114 78.116 24 246.440
2026-01-02 2025-12-30 4 Sarraf Pasha CUE Common Stock P - Purchase D 0,3174 86.947 28 168.324
2026-01-02 2025-12-30 4 Sarraf Pasha CUE Common Stock P - Purchase D 0,3003 77.148 23 81.377
2026-01-02 2025-12-30 4 Sarraf Pasha CUE Common Stock P - Purchase D 0,3094 4.229 1 4.229
2024-12-18 2024-12-16 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 1,0300 30.000 31 164.578
2024-06-07 3 Fox Michael J By MF Capital Partners, LLC CUE Common Stock I 100.000
2024-06-07 3 Fox Michael J By Park City Capital Offshore Master, Ltd. CUE Common Stock I 1.000.000
2023-08-29 2023-08-25 4 Suri Anish CUE Common Stock P - Purchase D 2,7600 4.000 11 135.638
2023-08-16 2023-08-14 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 2,8600 3.000 9 134.578
2023-04-13 3 Verheyen Patrick CUE Common Stock D 8.174
2023-03-27 2023-03-23 4 Kiener Peter A CUE Common Stock S - Sale D 3,2800 -9.325 -31 357
2023-03-27 2023-03-23 4 Kiener Peter A CUE Common Stock M - Exercise D 2,8600 9.682 28 9.682
2023-01-19 3 Levisetti Matteo CUE Common Stock D 9.230
2022-08-23 2022-08-22 4 Millar Kerri-Ann CUE Common Stock F - Taxes D 3,0500 -2.828 -9 14.311
2022-08-23 2022-08-21 4 Millar Kerri-Ann CUE Common Stock M - Exercise D 6.667 17.139
2022-06-16 2022-06-14 4 Gray Cameron CUE Common Stock F - Taxes D 3,2000 -51.562 -165 687.049
2022-06-16 2022-06-14 4 Gray Cameron CUE Common Stock X - Other D 2,7000 61.111 165 738.611
2022-05-31 2022-05-27 4 Morich Frank CUE Common Stock P - Purchase D 3,7500 28.000 105 28.000
2022-05-25 2022-05-24 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase I 3,3400 55.000 184 940.000
2022-05-25 2022-05-23 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase I 3,5200 150.000 528 885.000
2022-04-04 2022-03-31 4 Suri Anish CUE Restricted Stock Units M - Exercise D -16.668 0
2022-04-04 2022-03-31 4 Suri Anish CUE Common Stock F - Taxes D 4,8800 -7.068 -34 103.638
2022-04-04 2022-03-31 4 Suri Anish CUE Common Stock M - Exercise D 16.668 110.706
2022-04-04 2022-03-31 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase I 4,7600 735.000 3.499 735.000
2022-04-04 2022-03-31 4 PASSERI DANIEL R CUE Restricted Stock Units M - Exercise D -75.000 0
2022-04-04 2022-03-31 4 PASSERI DANIEL R CUE Common Stock G - Gift D -10.000 131.578
2022-04-04 2022-03-31 4 PASSERI DANIEL R CUE Common Stock F - Taxes D 4,8800 -32.122 -157 141.578
2022-04-04 2022-03-31 4 PASSERI DANIEL R CUE Common Stock M - Exercise D 75.000 173.700
2022-03-29 2022-03-25 4 NASSHORN PATRICIA CUE Stock Option (right to buy) A - Award D 5,01 10.000 10.000
2022-03-29 2022-03-25 4 Suri Anish CUE Stock Option (right to buy) A - Award D 5,01 21.333 21.333
2022-03-29 2022-02-09 4 Suri Anish CUE Stock Option (right to buy) A - Award D 6,91 82.000 82.000
2022-03-29 2022-03-25 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 5,01 16.667 16.667
2022-03-29 2022-02-09 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 6,91 60.000 60.000
2022-03-29 2022-03-25 4 Pienta Kenneth CUE Stock Option (right to buy) A - Award D 5,01 40.000 40.000
2022-03-29 2022-03-25 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 5,01 100.000 100.000
2022-03-29 2022-03-25 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 5,01 10.000 10.000
2022-03-29 2022-02-09 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 6,91 85.000 85.000
2022-01-05 2022-01-03 4 Fletcher Aaron G.L. CUE Stock Option (right to buy) A - Award D 12,28 10.000 10.000
2022-01-05 2022-01-03 4 Kiener Peter A CUE Stock Option (right to buy) A - Award D 12,28 10.000 10.000
2022-01-05 2022-01-03 4 Morich Frank CUE Stock Option (right to buy) A - Award D 12,28 10.000 10.000
2022-01-05 2022-01-03 4 HOWSON TAMAR D CUE Stock Option (right to buy) A - Award D 12,28 10.000 10.000
2022-01-05 2022-01-03 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 12,28 10.000 10.000
2022-01-05 2022-01-03 4 Gray Cameron CUE Stock Option (right to buy) A - Award D 12,28 10.000 10.000
2022-01-04 2021-12-15 4 NASSHORN PATRICIA CUE Stock Option (right to buy) A - Award D 11,24 100.000 100.000
2021-12-21 2021-12-20 4 Pienta Kenneth CUE Stock Option (right to buy) A - Award D 11,45 80.000 80.000
2021-11-17 2021-11-16 4 Kiener Peter A CUE Stock Option (right to buy) M - Exercise D 2,86 -1.361 105.744
2021-11-17 2021-11-16 4 Kiener Peter A CUE Common Stock S - Sale D 18,0200 -1.361 -25 0
2021-11-17 2021-11-16 4 Kiener Peter A CUE Common Stock M - Exercise D 2,8600 1.361 4 1.361
2021-11-17 2021-11-15 4 Kiener Peter A CUE Stock Option (right to buy) M - Exercise D 2,86 -18.815 107.105
2021-11-17 2021-11-15 4 Kiener Peter A CUE Common Stock S - Sale D 17,9200 -18.815 -337 0
2021-11-17 2021-11-15 4 Kiener Peter A CUE Common Stock M - Exercise D 2,8600 18.815 54 18.815
2021-11-17 2021-11-15 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 8,26 -8.000 10.000
2021-11-17 2021-11-15 4 Suri Anish CUE Common Stock S - Sale D 18,0500 -8.000 -144 94.038
2021-11-17 2021-11-15 4 Suri Anish CUE Common Stock M - Exercise D 8,2600 8.000 66 102.038
2021-11-15 2021-11-11 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6,42 -20.000 105.000
2021-11-15 2021-11-11 4 Suri Anish CUE Common Stock S - Sale D 15,0677 -20.000 -301 94.038
2021-11-15 2021-11-11 4 Suri Anish CUE Common Stock M - Exercise D 6,4200 20.000 128 114.038
2021-10-08 2021-10-06 4 Suri Anish CUE Common Stock F - Taxes D 12,9700 -14.134 -183 94.038
2021-10-08 2021-10-03 4 Suri Anish CUE Restricted Stock Units M - Exercise D -33.334 0
2021-10-08 2021-10-03 4 Suri Anish CUE Common Stock M - Exercise D 33.334 108.172
2021-10-08 2021-09-30 4 PASSERI DANIEL R CUE Restricted Stock Units M - Exercise D -75.000 75.000
2021-10-08 2021-09-30 4 PASSERI DANIEL R CUE Common Stock F - Taxes D 14,5700 -31.677 -462 98.700
2021-10-08 2021-09-30 4 PASSERI DANIEL R CUE Common Stock M - Exercise D 75.000 130.377
2021-10-05 2021-10-01 4 Millar Kerri-Ann CUE Stock Option (right to buy) M - Exercise D 7,50 -1.251 53.749
2021-10-05 2021-10-01 4 Millar Kerri-Ann CUE Common Stock S - Sale D 14,2149 -1.251 -18 10.472
2021-10-05 2021-10-01 4 Millar Kerri-Ann CUE Common Stock M - Exercise D 7,5000 1.251 9 11.723
2021-10-05 2021-08-23 4 Millar Kerri-Ann CUE Restricted Stock Units M - Exercise D -6.667 6.667
2021-10-05 2021-08-23 4 Millar Kerri-Ann CUE Common Stock F - Taxes D -1.961 10.472
2021-10-05 2021-08-23 4 Millar Kerri-Ann CUE Common Stock M - Exercise D 6.667 12.433
2021-09-27 2021-09-24 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 14,7210 3.400 50 55.377
2021-09-27 2021-09-23 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6,42 -20.000 125.000
2021-09-27 2021-09-23 4 Suri Anish CUE Common Stock S - Sale D 15,2323 -20.000 -305 74.838
2021-09-27 2021-09-23 4 Suri Anish CUE Common Stock M - Exercise D 6,4200 20.000 128 94.838
2021-03-17 2021-03-16 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 5,00 -439 133.567
2021-03-17 2021-03-16 4 Pienta Kenneth CUE Common Stock S - Sale D 15,0926 -439 -7 2.000
2021-03-17 2021-03-16 4 Pienta Kenneth CUE Common Stock M - Exercise D 5,0000 439 2 2.439
2021-03-17 2021-03-15 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 5,00 -13.000 134.006
2021-03-17 2021-03-15 4 Pienta Kenneth CUE Common Stock S - Sale D 15,0976 -13.000 -196 2.000
2021-03-17 2021-03-15 4 Pienta Kenneth CUE Common Stock M - Exercise D 5,0000 13.000 65 15.000
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 5,00 -2.994 147.006
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 2,86 -1.280 0
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Common Stock S - Sale D 15,0550 -4.274 -64 2.000
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Common Stock M - Exercise D 5,0000 2.994 15 6.274
2021-02-18 2021-02-17 4 Pienta Kenneth CUE Common Stock M - Exercise D 2,8600 1.280 4 3.280
2021-02-18 2021-02-16 4 Pienta Kenneth CUE Stock Option (right to buy) M - Exercise D 2,86 -16.000 1.280
2021-02-18 2021-02-16 4 Pienta Kenneth CUE Common Stock S - Sale D 15,1514 -16.000 -242 2.000
2021-02-18 2021-02-16 4 Pienta Kenneth CUE Common Stock M - Exercise D 2,8600 16.000 46 18.000
2021-02-18 2021-01-20 4/A Pienta Kenneth CUE Common Stock S - Sale D 15,0660 -2.720 -41 2.000
2021-02-18 2021-01-20 4/A Pienta Kenneth CUE Common Stock M - Exercise D 2,8600 2.720 8 4.720
2021-02-12 2021-02-10 4 Pienta Kenneth CUE Stock Option (right to buy) A - Award D 15,55 50.000 50.000
2021-02-12 2021-02-10 4 Suri Anish CUE Stock Option (right to buy) A - Award D 15,55 75.000 75.000
2021-02-12 2021-02-10 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 15,55 85.000 85.000
2021-02-12 2021-02-10 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 15,55 70.000 70.000
2021-02-12 2021-02-10 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 15,55 50.000 50.000
2021-02-01 2020-12-02 5 Gray Cameron By Julie Heider Nongrantor Pot Trust under the Julie Heider 2020 Irrevocable Trust CUE Common Stock G - Gift I 271.000 271.000
2021-02-01 2020-12-02 5 Gray Cameron By Family Nongrantor Pot Trust under the Cameron Gray 2020 Irrevocable Trust CUE Common Stock G - Gift I 162.600 162.600
2021-02-01 2020-12-02 5 Gray Cameron By Extended Family Nongrantor Pot Trust under the Cameron Gray 2020 Irrevocable Trust CUE Common Stock G - Gift I 162.600 162.600
2021-02-01 2020-12-02 5 Gray Cameron CUE Common Stock G - Gift D -596.200 81.300
2021-01-22 2021-01-20 4 Pienta Kenneth CUE Common Stock P - Purchase D 15,0660 2.720 41 4.720
2021-01-06 2021-01-04 4 Simon Barry J. CUE Stock Option (right to buy) A - Award D 12,36 10.000 10.000
2021-01-06 2021-01-04 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 12,36 10.000 10.000
2021-01-06 2021-01-04 4 Kiener Peter A CUE Stock Option (right to buy) A - Award D 12,36 10.000 10.000
2021-01-06 2021-01-04 4 Morich Frank CUE Stock Option (right to buy) A - Award D 12,36 10.000 10.000
2021-01-06 2021-01-04 4 Fletcher Aaron G.L. CUE Stock Option (right to buy) A - Award D 12,36 10.000 10.000
2021-01-06 2021-01-04 4 Gray Cameron CUE Stock Option (right to buy) A - Award D 12,36 10.000 10.000
2021-01-06 2021-01-04 4 HOWSON TAMAR D CUE Stock Option (right to buy) A - Award D 12,36 10.000 10.000
2020-11-25 2020-11-24 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase D 12,6414 6.548 83 165.000
2020-10-06 2020-10-05 4 Suri Anish CUE Common Stock F - Taxes D 16,3000 -9.800 -160 58.091
2020-10-06 2020-10-03 4 Suri Anish CUE Restricted Stock Units M - Exercise D -33.333 33.334
2020-10-06 2020-10-03 4 Suri Anish CUE Common Stock M - Exercise D 33.333 67.891
2020-10-01 2020-09-30 4 Gray Cameron CUE Common Stock P - Purchase D 15,3000 5.000 76 677.500
2020-10-01 2020-09-29 4 Gray Cameron CUE Common Stock P - Purchase D 15,0000 5.000 75 672.500
2020-09-18 2020-09-17 4 HOWSON TAMAR D CUE Stock Option (right to buy) A - Award D 17,21 50.000 50.000
2020-08-25 2020-08-24 4 Millar Kerri-Ann CUE Common Stock F - Taxes D -1.900 5.766
2020-08-25 2020-08-21 4 Millar Kerri-Ann CUE Restricted Stock Units M - Exercise D -6.666 13.334
2020-08-25 2020-08-21 4 Millar Kerri-Ann CUE Restricted Stock Units A - Award D 20.000 20.000
2020-08-25 2020-08-21 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 19,87 65.000 65.000
2020-08-25 2020-08-21 4 Millar Kerri-Ann CUE Common Stock M - Exercise D 6.666 7.666
2020-08-10 2020-08-05 4/A Sandercock Colin CUE Stock Option (right to buy) M - Exercise D 7,50 -13.374 130.000
2020-08-10 2020-08-05 4/A Sandercock Colin CUE Common Stock S - Sale D 20,0000 -13.374 -267 17.125
2020-08-10 2020-08-05 4/A Sandercock Colin CUE Common Stock M - Exercise D 7,5000 13.374 100 30.499
2020-08-07 2020-08-05 4 Sandercock Colin CUE Stock Option (right to buy) M - Exercise D 7,50 -13.274 130.100
2020-08-07 2020-08-05 4 Sandercock Colin CUE Common Stock S - Sale D 20,0000 -13.274 -265 17.125
2020-08-07 2020-08-05 4 Sandercock Colin CUE Common Stock M - Exercise D 7,5000 13.274 100 30.399
2020-08-07 2020-08-05 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6,42 -800 145.000
2020-08-07 2020-08-05 4 Suri Anish CUE Common Stock S - Sale D 20,0100 -800 -16 34.558
2020-08-07 2020-08-05 4 Suri Anish CUE Common Stock M - Exercise D 6,4200 800 5 35.358
2020-08-05 2020-08-04 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6,42 -400 145.800
2020-08-05 2020-08-04 4 Suri Anish CUE Common Stock S - Sale D 20,1400 -400 -8 34.558
2020-08-05 2020-08-04 4 Suri Anish CUE Common Stock M - Exercise D 6,4200 400 3 34.958
2020-08-05 2020-08-03 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 6,42 -3.800 146.200
2020-08-05 2020-08-03 4 Suri Anish CUE Stock Option (right to buy) M - Exercise D 8,26 -2.000 18.000
2020-08-05 2020-08-03 4 Suri Anish CUE Common Stock S - Sale D 20,0100 -5.800 -116 34.558
2020-08-05 2020-08-03 4 Suri Anish CUE Common Stock M - Exercise D 6,4200 3.800 24 40.358
2020-08-05 2020-08-03 4 Suri Anish CUE Common Stock M - Exercise D 8,2600 2.000 17 36.558
2020-08-05 2020-08-04 4 Sandercock Colin CUE Stock Option (right to buy) M - Exercise D 7,50 -201 143.374
2020-08-05 2020-08-04 4 Sandercock Colin CUE Common Stock S - Sale D 20,0500 -201 -4 17.125
2020-08-05 2020-08-04 4 Sandercock Colin CUE Common Stock M - Exercise D 7,5000 201 2 17.326
2020-08-05 2020-08-03 4 Sandercock Colin CUE Stock Option (right to buy) M - Exercise D 7,50 -6.425 143.575
2020-08-05 2020-08-03 4 Sandercock Colin CUE Common Stock S - Sale D 20,0000 -6.425 -128 17.125
2020-08-05 2020-08-03 4 Sandercock Colin CUE Common Stock M - Exercise D 7,5000 6.425 48 23.550
2020-06-25 2020-06-24 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase D 25,2400 2.953 75 158.452
2020-06-25 2020-06-24 4 Fletcher Aaron G.L. CUE Common Stock P - Purchase D 24,6400 4.547 112 155.499
2020-05-12 2020-05-11 4 Morich Frank CUE Stock Option (right to buy) A - Award D 27,56 1.200 1.200
2020-04-10 2020-03-31 4 Suri Anish CUE Restricted Stock Units M - Exercise D -16.666 100.001
2020-04-10 2020-03-31 4 Suri Anish CUE Restricted Stock Units A - Award D 50.000 116.667
2020-04-10 2020-03-31 4 Suri Anish CUE Common Stock F - Taxes D -5.354 34.558
2020-04-10 2020-03-31 4 Suri Anish CUE Common Stock M - Exercise D 16.666 39.912
2020-03-26 2020-03-24 4 Pienta Kenneth CUE Stock Option (right to buy) A - Award D 14,00 100.000 100.000
2020-02-24 2019-06-10 4/A Sandercock Colin CUE Common Stock P - Purchase D 7,9000 15.025 119 17.125
2020-02-24 2019-06-07 4/A Sandercock Colin CUE Common Stock P - Purchase D 7,3500 100 1 2.100
2020-02-12 2020-02-05 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 16,26 150.000 150.000
2020-02-12 2020-02-05 4 PASSERI DANIEL R CUE Restricted Stock Units A - Award D 150.000 150.000
2020-02-12 2020-02-05 4 Suri Anish CUE Stock Option (right to buy) A - Award D 16,26 65.000 65.000
2020-02-12 2020-02-05 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 16,26 30.000 30.000
2020-02-12 2020-02-05 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 16,26 20.000 20.000
2020-01-06 2020-01-02 4 Morich Frank CUE Stock Option (right to buy) A - Award D 16,31 8.000 8.000
2020-01-06 2020-01-02 4 Simon Barry J. CUE Stock Option (right to buy) A - Award D 16,31 9.600 9.600
2020-01-06 2020-01-02 4 Fletcher Aaron G.L. CUE Stock Option (right to buy) A - Award D 16,31 8.000 8.000
2020-01-06 2020-01-02 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 16,31 8.000 8.000
2020-01-06 2020-01-02 4 Gray Cameron CUE Stock Option (right to buy) A - Award D 16,31 8.000 8.000
2020-01-06 2020-01-02 4 Kiener Peter A CUE Stock Option (right to buy) A - Award D 16,31 8.000 8.000
2020-01-06 2020-01-02 4 MARLETT CHRISTOPHER A CUE Stock Option (right to buy) A - Award D 16,31 8.000 8.000
2020-01-06 2020-01-02 4 MCKNIGHT STEVEN L CUE Stock Option (right to buy) A - Award D 16,31 8.000 8.000
2019-12-31 2019-12-31 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale D 15,7100 -9.000 -141 0
2019-12-31 2019-12-31 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 15,7700 -6.700 -106 768.503
2019-12-31 2019-12-27 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 17,2400 -9.000 -155 775.203
2019-12-27 2019-12-26 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 17,5300 -19.647 -344 784.203
2019-12-27 2019-12-23 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 16,8200 -17.000 -286 803.850
2019-12-19 2019-12-19 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 17,0000 -4.000 -68 820.850
2019-12-19 2019-12-17 4 MARLETT CHRISTOPHER A CUE Common Stock S - Sale I 15,7300 -20.732 -326 824.850
2019-12-19 2019-12-12 4 MARLETT CHRISTOPHER A CUE Common Stock J - Other I 755.980 845.582
2019-12-19 2019-12-12 4 MARLETT CHRISTOPHER A CUE Common Stock J - Other I -1.007.973 0
2019-11-04 2019-11-01 4 Suri Anish CUE Restricted Stock Units M - Exercise D -33.333 66.667
2019-11-04 2019-11-01 4 Suri Anish CUE Common Stock F - Taxes D 8,6300 -12.087 -104 23.246
2019-11-04 2019-11-01 4 Suri Anish CUE Common Stock M - Exercise D 33.333 35.333
2019-10-07 2019-10-03 4 Suri Anish CUE Restricted Stock Units A - Award D 100.000 0
2019-10-07 2019-10-03 4 Suri Anish CUE Stock Option (right to buy) A - Award D 7,53 7,5300 400.000 3.012 400.000
2019-10-07 3 Fletcher Aaron G.L. By spouse CUE Common Stock I 168.686
2019-10-07 3 Fletcher Aaron G.L. CUE Common Stock D 310.771
2019-10-07 3 Fletcher Aaron G.L. By spouse CUE Common Stock I 168.686
2019-10-07 3 Fletcher Aaron G.L. CUE Common Stock D 310.771
2019-10-07 3 Fletcher Aaron G.L. By spouse CUE Common Stock I 168.686
2019-10-07 3 Fletcher Aaron G.L. CUE Common Stock D 310.771
2019-10-07 2019-10-03 4 Fletcher Aaron G.L. CUE Stock Option (right to buy) A - Award D 7,53 50.000 50.000
2019-06-25 2019-06-21 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 7,2600 1.377 10 51.977
2019-06-10 2019-06-10 4 Sandercock Colin CUE Common Stock P - Purchase D 7,9300 14.938 118 16.938
2019-06-10 2019-06-06 4 Sandercock Colin CUE Common Stock P - Purchase D 7,1000 2.000 14 2.000
2019-06-07 2019-06-06 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 6,9000 3.000 21 50.600
2019-03-08 2019-03-06 4 Mancilla Bethany CUE Stock Option (right to buy) A - Award D 9,54 100.000 100.000
2019-03-08 2019-03-06 4 Mancilla Bethany CUE Stock Option (right to buy) A - Award D 6,42 65.000 65.000
2019-03-08 2019-03-06 4 Suri Anish CUE Stock Option (right to buy) A - Award D 11,54 100.000 100.000
2019-03-08 2019-03-06 4 Suri Anish CUE Stock Option (right to buy) A - Award D 6,42 150.000 150.000
2019-03-08 2019-03-06 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 11,54 100.000 100.000
2019-03-08 2019-03-06 4 PASSERI DANIEL R CUE Stock Option (right to buy) A - Award D 6,42 125.000 125.000
2019-03-08 2019-03-06 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 6,42 30.000 30.000
2019-03-08 2019-03-06 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 7,50 100.000 100.000
2019-03-08 2019-03-06 4 Sandercock Colin CUE Stock Option (right to buy) A - Award D 6,42 50.000 50.000
2019-01-28 2017-12-29 4 Gray Cameron CUE Warrants J - Other D 9,38 192.495 192.495
2019-01-28 2017-12-29 4 MARLETT CHRISTOPHER A CUE Warrants J - Other I 9,38 -416.656 416.656
2019-01-15 2018-07-10 5 MARLETT CHRISTOPHER A CUE Common Stock G - Gift I -9.000 1.007.973
2019-01-15 2018-04-05 5 MARLETT CHRISTOPHER A CUE Common Stock G - Gift I -1.000 1.016.973
2019-01-04 2018-12-24 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 4,8100 10.000 48 30.000
2019-01-03 2019-01-02 4 DIGIANDOMENICO ANTHONY CUE Stock Option (right to buy) A - Award D 5,16 8.000 8.000
2019-01-03 2019-01-02 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 5,16 8.000 8.000
2019-01-03 2019-01-02 4 Gray Cameron CUE Stock Option (right to buy) A - Award D 5,16 8.000 8.000
2019-01-03 2019-01-02 4 Kiener Peter A CUE Stock Option (right to buy) A - Award D 5,16 8.000 8.000
2019-01-03 2019-01-02 4 MARLETT CHRISTOPHER A CUE Stock Option (right to buy) A - Award D 5,16 8.000 8.000
2019-01-03 2019-01-02 4 MCKNIGHT STEVEN L CUE Stock Option (right to buy) A - Award D 5,16 8.000 8.000
2019-01-03 2019-01-02 4 Morich Frank CUE Stock Option (right to buy) A - Award D 5,16 8.000 8.000
2019-01-03 2019-01-02 4 Simon Barry J. CUE Stock Option (right to buy) A - Award D 5,16 9.600 9.600
2019-01-02 2018-12-28 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 4,6200 7.000 32 57.000
2019-01-02 2018-12-31 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4,6400 18.521 86 89.602
2018-12-28 2018-12-27 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 4,7700 20.000 95 50.000
2018-12-27 2018-12-26 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4,2900 19.647 84 71.081
2018-12-26 2018-12-21 4 Suri Anish CUE Common Stock P - Purchase D 4,3700 2.000 9 2.000
2018-12-26 2018-12-21 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 4,4900 10.000 45 20.000
2018-12-26 2018-12-21 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4,5300 17.200 78 51.434
2018-12-21 2018-12-20 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4,7400 9.438 45 34.234
2018-12-20 2018-12-19 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 5,0000 400 2 24.796
2018-12-19 2018-12-18 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 5,2000 3.664 19 24.396
2018-12-18 2018-12-17 4 DIGIANDOMENICO ANTHONY CUE Common Stock P - Purchase D 5,4800 10.000 55 10.000
2018-12-17 2018-12-13 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 5,0600 10.000 51 20.732
2018-12-13 2018-12-12 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 5,0700 3.189 16 10.732
2018-12-13 2018-12-12 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase D 5,0900 9.000 46 9.000
2018-12-12 2018-12-11 4 MARLETT CHRISTOPHER A CUE Common Stock P - Purchase I 4,8600 7.543 37 7.543
2018-08-29 2018-08-29 4 Millar Kerri-Ann CUE Common Stock P - Purchase D 8,4800 1.000 8 1.000
2018-08-20 2018-08-16 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 8,0850 6.000 49 47.600
2018-08-16 2018-08-14 4 Suri Anish CUE Stock Option (right to buy) A - Award D 8,26 20.000 20.000
2018-08-02 3 Morich Frank CUE No securities are beneficially owned D 0
2018-08-02 2018-07-31 4 Morich Frank CUE Stock Option (right to buy) A - Award D 9,06 50.000 50.000
2018-08-02 3 Mancilla Bethany CUE No securities are beneficially owned D 0
2018-08-02 2018-08-01 4 Mancilla Bethany CUE Stock Option (right to buy) A - Award D 9,54 250.000 250.000
2018-07-25 2018-07-23 4 Chaparro Rodolfo CUE Stock Option (right to buy) A - Award D 11,54 75.000 75.000
2018-07-25 2018-07-23 4 Seidel Ronald D. III CUE Stock Option (right to buy) A - Award D 11,54 75.000 75.000
2018-07-25 2018-07-23 4 Millar Kerri-Ann CUE Stock Option (right to buy) A - Award D 11,54 50.000 50.000
2018-06-29 2018-06-29 4 PASSERI DANIEL R CUE Common Stock P - Purchase D 11,9700 1.600 19 41.600
2018-06-27 2018-06-26 4 DRISCOLL FREDERICK W CUE Stock Option (right to buy) A - Award D 12,97 50.000 50.000
2018-06-27 3 DRISCOLL FREDERICK W CUE No securities are beneficially owned D 0
2018-06-14 2018-06-12 4 Gray Cameron CUE Stock Option (right to buy) M - Exercise D 14,24 8.000 8.000
2018-06-14 2018-06-12 4 MCKNIGHT STEVEN L CUE Stock Option (right to buy) M - Exercise D 14,24 8.000 8.000
2018-06-14 2018-06-12 4 Simon Barry J. CUE Stock Option (Right to Buy) M - Exercise D 14,24 8.000 8.000
2018-06-14 2018-06-12 4 MARLETT CHRISTOPHER A CUE Stock Option (right to buy) M - Exercise D 14,24 8.000 8.000
2018-06-14 2018-06-12 4 Kiener Peter A CUE Stock Option (right to buy) M - Exercise D 14,24 9.600 9.600
2018-06-14 2018-06-12 4 DIGIANDOMENICO ANTHONY CUE Stock Option (right to buy) M - Exercise D 14,24 8.000 8.000
2018-05-16 3 Suri Anish CUE No securities are beneficially owned D 0
2018-05-16 2018-05-14 4 Suri Anish CUE Stock Options A - Award D 14,32 250.000 250.000
2018-01-19 2017-12-27 4 Pienta Kenneth CUE Common Stock P - Purchase D 7,5000 2.000 15 2.000
2017-12-29 2017-12-27 4 MARLETT CHRISTOPHER A CUE Warrants A - Award I 9,38 833.312 833.312
2017-12-27 3 Chaparro Rodolfo CUE Common Stock D 890.000
2017-12-27 3 Chaparro Rodolfo CUE Common Stock D 890.000
2017-12-27 3 DIGIANDOMENICO ANTHONY CUE No securities are beneficially owned D 0
2017-12-27 3 Gray Cameron CUE Common Stock D 1.335.000
2017-12-27 3 Gray Cameron CUE Common Stock D 1.335.000
2017-12-27 3 PASSERI DANIEL R CUE Common Stock D 80.000
2017-12-27 3 PASSERI DANIEL R CUE Common Stock D 80.000
2017-12-27 3 Sandercock Colin CUE No securities are beneficially owned D 0
2017-12-27 3 SCHUMAN GARY ALAN CUE Common Stock D 133.500
2017-12-27 3 SCHUMAN GARY ALAN CUE Common Stock D 133.500
2017-12-27 3 Seidel Ronald D. III CUE Common Stock D 890.000
2017-12-27 3 Seidel Ronald D. III CUE Common Stock D 890.000
2017-12-27 3 MARLETT CHRISTOPHER A CUE Common Stock I 2.035.946
2017-12-27 3 MARLETT CHRISTOPHER A CUE Common Stock I 2.035.946
2017-12-27 2017-12-27 4 Sandercock Colin CUE Stock Options A - Award D 7,50 150.000 150.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista